Showing 1 - 6 results of 6 for search 'Matthew J. Bott', query time: 0.04s
Refine Results
-
1
A Novel Frailty Index Can Predict the Short-Term Outcomes of Esophagectomy in Older Patients with Esophageal Cancer by Thomas Boerner, Marisa Sewell, Amy L. Tin, Andrew J. Vickers, Caitlin Harrington-Baksh, Manjit S. Bains, Matthew J. Bott, Bernard J. Park, Smita Sihag, David R. Jones, Robert J. Downey, Armin Shahrokni, Daniela Molena
Published 2024-08-01
Article -
2
Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinoma by Raul Caso, James G. Connolly, Jian Zhou, Kay See Tan, James J. Choi, Gregory D. Jones, Brooke Mastrogiacomo, Francisco Sanchez-Vega, Bastien Nguyen, Gaetano Rocco, Daniela Molena, Smita Sihag, Prasad S. Adusumilli, Matthew J. Bott, David R. Jones
Published 2021-07-01
Article -
3
The incremental contribution of mobile cone-beam computed tomography to the tool–lesion relationship during shape-sensing robotic-assisted bronchoscopy by Bryan C. Husta, Anu Menon, Reza Bergemann, I-Hsin Lin, Jaclyn Schmitz, Rastko Rakočević, Tejaswi R. Nadig, Prasad S. Adusumilli, Jason A. Beattie, Robert P. Lee, Bernard J. Park, Gaetano Rocco, Matthew J. Bott, Mohit Chawla, Or Kalchiem-Dekel
Published 2024-07-01
Article -
4
Clinicopathologic and genomic features associated with brain metastasis after resection of lung adenocarcinomaCentral MessagePerspective by Elizabeth G. Dunne, MD, Cameron N. Fick, MD, Brooke Mastrogiacomo, MS, Kay See Tan, PhD, Nicolas Toumbacaris, MSPH, Stijn Vanstraelen, MD, Gaetano Rocco, MD, Jaime E. Chaft, MD, Puneeth Iyengar, MD, Daniel Gomez, MD, Prasad S. Adusumilli, MD, Bernard J. Park, MD, James M. Isbell, MD, Matthew J. Bott, MD, Smita Sihag, MD, Daniela Molena, MD, James Huang, MD, David R. Jones, MD
Published 2024-12-01
Article -
5
Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes by Jennie K. Choe, MD, Amy Zhu, BS, Alexander J. Byun, MD, Junting Zheng, MS, Kay See Tan, PhD, Joe Dycoco, BS, Manjit S. Bains, MD, Matthew J. Bott, MD, Robert J. Downey, MD, James Huang, MD, James M. Isbell, MD, Daniela Molena, MD, Valerie W. Rusch, MD, Bernard J. Park, MD, Gaetano Rocco, MD, Smita Sihag, MD, David R. Jones, MD, Prasad S. Adusumilli, MD, FACS
Published 2022-08-01
Article -
6
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations by Kathryn C. Arbour, MD, Eusebio Manchado, PhD, Matthew J. Bott, MD, Linda Ahn, NP, Yosef Tobi, BA, Andy Ai Ni, Helena A. Yu, MD, Alyssa Shannon, BA, Marc Ladanyi, MD, Victoria Perron, BS, Michelle S. Ginsberg, MD, Amanda Johnson, BA, Andrei Holodny, MD, Mark G. Kris, MD, Charles M. Rudin, MD, PhD, Piro Lito, MD, PhD, Neal Rosen, MD, PhD, Scott Lowe, PhD, Gregory J. Riely, MD, PhD
Published 2022-01-01
Article